Jerry Chapman has over 40 years of experience in the pharmaceutical industry, including numerous positions in development, manufacturing, and quality at the plant, site, and corporate levels. He designed and implemented a comprehensive “GMP Intelligence” process at Eli Lilly and again at Elanco. Chapman served as senior editor at International Pharmaceutical Quality for six years and as Editor-in-Chief at Xavier Health, in both positions keeping abreast of the latest developments in the drug GMP space internationally. He consulted with sterile compounding firms through Clarke Solutions. Jerry is currently Senior GMP Quality Expert at FDAzilla, a company that is at the forefront of leveraging the power of Big Data and AI to make government data accessible, usable and valuable to everyone who needs it.